Intuitive Venture Partners | Venture Capital Firms NYC | Investment Bank New York City
Transactions News Contact Login
The FIRM Testimonials
Managing Partners Business Relationships
Investment Banking Services Proprietary Investment Opportunities
About The FIRM Testimonials Team Managing Partners Business Relationships Services Investment Banking Services Proprietary Investment Opportunities TransactionsNewsContactLogin
Intuitive Venture Partners | Venture Capital Firms NYC | Investment Bank New York City
Lumicell’s Cutting-Edge Imaging Platform Receives Historic FDA Approval to Illuminate Residual Breast Cancer
Intuitive Venture PartnersApril 18, 20242024, Lumicell
Facebook0 Twitter LinkedIn0 Reddit Tumblr 0 Likes
Previous

Guerrilla RF Completes Strategic Acquisition of GaN Device Portfolio from Gallium Semiconductor

Intuitive Venture PartnersApril 29, 2024Guerilla, 2024
Next

Serve Robotics Inc. Announces Pricing of $40 Million Public Offering and Uplisting to the Nasdaq Capital Market Under New Ticker "SERV"

Intuitive Venture PartnersApril 17, 20242024, Serve Robotics

Intuitive Venture Partners, LLC. • 777 Westchester Ave, Suite 101 • White Plains, NY 10604

Intuitive Venture Partners
777 Westchester Avenue,
White Plains, NY, 10604,
United States
212-612-3221 info@intuitivevp.com
Hours
Mon 8am - 5pm
Tue 8am - 5pm
Wed 8am - 5pm
Thu 8am - 5pm
Fri 8am - 5pm
 

2023 INTUITIVE VENTURE PARTNERS, LLC. ALL RIGHTS RESERVED. SECURITIES OFFERED THROUGH
NETWORK 1 FINANCIAL SECURITIES, INC., A REGISTERED BROKER-DEALER, MEMBER FINRA AND SIPC

broker-check-sml.png
Terms of UseContact